ReP USP - Resultado da busca

Artigo de periodico
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB) (2022)
Sassaki, ligia Yukie; Magro, Daniela Oliveira; Saad-Hossne, Rogerio; Baima, Julio Pinheiro; Flores, Cristina; Correia, Lucianna Motta; Celani, Lívia Medeiros Soares; Ferrari, Maria de Lourdes de Abreu; Zacharias, Patrícia; Feitosa, Marley Ribeiro ; Santos, Carlos Henrique Marques dos; Lins Neto, Manoel Àlvaro de Freitas
Source: BMC Gastroenterology. Unidade: FMRP
Subjects: ANTICORPOS MONOCLONAIS, COLITE ULCERATIVA, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SASSAKI, ligia Yukie et al. Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB). BMC Gastroenterology, v. 22, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12876-022-02341-7. Acesso em: 01 nov. 2025.
APA
Sassaki, ligia Y., Magro, D. O., Saad-Hossne, R., Baima, J. P., Flores, C., Correia, L. M., et al. (2022). Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB). BMC Gastroenterology, 22, 1-12. doi:10.1186/s12876-022-02341-7
NLM
Sassaki ligia Y, Magro DO, Saad-Hossne R, Baima JP, Flores C, Correia LM, Celani LMS, Ferrari M de L de A, Zacharias P, Feitosa MR, Santos CHM dos, Lins Neto MÀ de F. Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB) [Internet]. BMC Gastroenterology. 2022 ; 22 1-12.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/s12876-022-02341-7
Vancouver
Sassaki ligia Y, Magro DO, Saad-Hossne R, Baima JP, Flores C, Correia LM, Celani LMS, Ferrari M de L de A, Zacharias P, Feitosa MR, Santos CHM dos, Lins Neto MÀ de F. Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB) [Internet]. BMC Gastroenterology. 2022 ; 22 1-12.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/s12876-022-02341-7
Artigo de periodico
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study (2022)
Parra, Rogério Serafim; Chebli, Júlio Maria Fonseca; Queiroz, Natália Sousa Freitas; Damião, Aderson Omar Mourão Cintra; Azevedo, Matheus Freitas Cardoso de; Chebli, Liliana Andrade; Bertges, Erika Ruback; Alves Junior, Antonio José Tiburcio; Ambrogini Junior, Orlando; Silva, Bianca Loyo Pona Schiavetti da; Lubini, Marcio; Bafutto, Mauro; Flores, Cristina; Vilela, Eduardo Garcia; Boratto, Sandra Felice; Gasparetti Júnior, Newton Luiz Tricarico; Steinwurz, Flavio; Carvalho, Nayara Salgado; Féres, Omar; Rocha, José Joaquim Ribeiro da
Source: BMC Gastroenterology. Unidades: FMRP, FM
Subjects: DOENÇA DE CROHN, ENTEROPATIAS INFLAMATÓRIAS, INTESTINOS, TERAPIA BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Rogério Serafim et al. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study. BMC Gastroenterology, v. 22, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12876-022-02280-3. Acesso em: 01 nov. 2025.
APA
Parra, R. S., Chebli, J. M. F., Queiroz, N. S. F., Damião, A. O. M. C., Azevedo, M. F. C. de, Chebli, L. A., et al. (2022). Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study. BMC Gastroenterology, 22. doi:10.1186/s12876-022-02280-3
NLM
Parra RS, Chebli JMF, Queiroz NSF, Damião AOMC, Azevedo MFC de, Chebli LA, Bertges ER, Alves Junior AJT, Ambrogini Junior O, Silva BLPS da, Lubini M, Bafutto M, Flores C, Vilela EG, Boratto SF, Gasparetti Júnior NLT, Steinwurz F, Carvalho NS, Féres O, Rocha JJR da. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study [Internet]. BMC Gastroenterology. 2022 ; 22[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/s12876-022-02280-3
Vancouver
Parra RS, Chebli JMF, Queiroz NSF, Damião AOMC, Azevedo MFC de, Chebli LA, Bertges ER, Alves Junior AJT, Ambrogini Junior O, Silva BLPS da, Lubini M, Bafutto M, Flores C, Vilela EG, Boratto SF, Gasparetti Júnior NLT, Steinwurz F, Carvalho NS, Féres O, Rocha JJR da. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study [Internet]. BMC Gastroenterology. 2022 ; 22[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/s12876-022-02280-3
Artigo de periodico
A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis (2020)
Nakano, Larissa Akeme ; Cançado, Eduardo Luiz Rachid ; Chaves, Cleuber Esteves ; Madeira, Maria Cristina Vaz; Katayose, Jéssica Toshie; Nabeshima, Mariana Akemi ; Fossaluza, Victor ; Uhrigshardt, Gabriela Guimarães; Liting, Zheng; Pinto, Vanusa Barbosa ; Carrilho, Flair José ; Ono, Suzane Kioko
Source: BMC Gastroenterology. Unidades: FM, IME
Subjects: GASTOS EM SAÚDE, ESTATÍSTICA DESCRITIVA, INFERÊNCIA ESTATÍSTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKANO, Larissa Akeme et al. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis. BMC Gastroenterology, v. 20, n. artigo 253, p. 253-261, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12876-020-01399-5. Acesso em: 01 nov. 2025.
APA
Nakano, L. A., Cançado, E. L. R., Chaves, C. E., Madeira, M. C. V., Katayose, J. T., Nabeshima, M. A., et al. (2020). A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis. BMC Gastroenterology, 20( artigo 253), 253-261. doi:10.1186/s12876-020-01399-5
NLM
Nakano LA, Cançado ELR, Chaves CE, Madeira MCV, Katayose JT, Nabeshima MA, Fossaluza V, Uhrigshardt GG, Liting Z, Pinto VB, Carrilho FJ, Ono SK. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis [Internet]. BMC Gastroenterology. 2020 ; 20( artigo 253): 253-261.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/s12876-020-01399-5
Vancouver
Nakano LA, Cançado ELR, Chaves CE, Madeira MCV, Katayose JT, Nabeshima MA, Fossaluza V, Uhrigshardt GG, Liting Z, Pinto VB, Carrilho FJ, Ono SK. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis [Internet]. BMC Gastroenterology. 2020 ; 20( artigo 253): 253-261.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/s12876-020-01399-5
Artigo de periodico
Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial (2016)
Gagliano-Jucá, Thiago; Moreno, Ronilson A.; Zaminelli, Tiago; Napolitano, Mauro; Magalhães, Antônio Frederico N.; Carvalhaes, Aloísio; Trevisan, Miriam S.; Wallace, John L.; De Nucci, Gilberto
Source: BMC Gastroenterology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GAGLIANO-JUCÁ, Thiago et al. Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial. BMC Gastroenterology, v. 16, n. 1, p. 1-7, 2016Tradução . . Disponível em: https://doi.org/10.1186/s12876-016-0472-x. Acesso em: 01 nov. 2025.
APA
Gagliano-Jucá, T., Moreno, R. A., Zaminelli, T., Napolitano, M., Magalhães, A. F. N., Carvalhaes, A., et al. (2016). Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial. BMC Gastroenterology, 16( 1), 1-7. doi:10.1186/s12876-016-0472-x
NLM
Gagliano-Jucá T, Moreno RA, Zaminelli T, Napolitano M, Magalhães AFN, Carvalhaes A, Trevisan MS, Wallace JL, De Nucci G. Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial [Internet]. BMC Gastroenterology. 2016 ; 16( 1): 1-7.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/s12876-016-0472-x
Vancouver
Gagliano-Jucá T, Moreno RA, Zaminelli T, Napolitano M, Magalhães AFN, Carvalhaes A, Trevisan MS, Wallace JL, De Nucci G. Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial [Internet]. BMC Gastroenterology. 2016 ; 16( 1): 1-7.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/s12876-016-0472-x
Artigo de periodico
A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study (2015)
Costa, Camila Ortiz Prospero Cavalcante; Carrilho, Flair José; Nunes, Valeria Sutti; Sipahi, Aytan Miranda; Rodrigues, Maraci
Source: BMC Gastroenterology. Unidade: FM
Subjects: ESTUDOS PROSPECTIVOS, ADOLESCENTES, DOENÇA DE CROHN (DIAGNÓSTICO), AVALIAÇÃO NUTRICIONAL, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Camila Ortiz Prospero Cavalcante et al. A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study. BMC Gastroenterology, v. 15, n. 172, p. 8 (online), 2015Tradução . . Disponível em: http://download.springer.com/static/pdf/211/art%253A10.1186%252Fs12876-015-0403-2.pdf?originUrl=http%3A%2F%2Fbmcgastroenterol.biomedcentral.com%2Farticle%2F10.1186%2Fs12876-015-0403-2&token2=exp=1456767538~acl=%2Fstatic%2Fpdf%2F211%2Fart%25253A10.1186%25252Fs12876-015-0403-2.pdf*~hmac=d85e2d8c1df83ffdad519ed52d8691d3e5def7147bc13e3367ef05804db67e5e. Acesso em: 01 nov. 2025.
APA
Costa, C. O. P. C., Carrilho, F. J., Nunes, V. S., Sipahi, A. M., & Rodrigues, M. (2015). A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study. BMC Gastroenterology, 15( 172), 8 (online). doi:10.1186/s12876-015-0403-2
NLM
Costa COPC, Carrilho FJ, Nunes VS, Sipahi AM, Rodrigues M. A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study [Internet]. BMC Gastroenterology. 2015 ; 15( 172): 8 (online).[citado 2025 nov. 01 ] Available from: http://download.springer.com/static/pdf/211/art%253A10.1186%252Fs12876-015-0403-2.pdf?originUrl=http%3A%2F%2Fbmcgastroenterol.biomedcentral.com%2Farticle%2F10.1186%2Fs12876-015-0403-2&token2=exp=1456767538~acl=%2Fstatic%2Fpdf%2F211%2Fart%25253A10.1186%25252Fs12876-015-0403-2.pdf*~hmac=d85e2d8c1df83ffdad519ed52d8691d3e5def7147bc13e3367ef05804db67e5e
Vancouver
Costa COPC, Carrilho FJ, Nunes VS, Sipahi AM, Rodrigues M. A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study [Internet]. BMC Gastroenterology. 2015 ; 15( 172): 8 (online).[citado 2025 nov. 01 ] Available from: http://download.springer.com/static/pdf/211/art%253A10.1186%252Fs12876-015-0403-2.pdf?originUrl=http%3A%2F%2Fbmcgastroenterol.biomedcentral.com%2Farticle%2F10.1186%2Fs12876-015-0403-2&token2=exp=1456767538~acl=%2Fstatic%2Fpdf%2F211%2Fart%25253A10.1186%25252Fs12876-015-0403-2.pdf*~hmac=d85e2d8c1df83ffdad519ed52d8691d3e5def7147bc13e3367ef05804db67e5e
Artigo de periodico
Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications (2014)
Leal, Mariana Ferreira; Mazzotti, Tatiane Katsue Furuya; Calcagno, Danielle Queiroz; Cirilo, Priscila Daniele Ramos; Martinez, Margarita Cortes; Demachki, Samia; Assumpção, Paulo Pimentel; Chammas, Roger; Burbano, Rommel Rodríguez; Smith, Marília Cardoso
Source: BMC Gastroenterology. Unidade: FM
Subjects: NÚCLEO CELULAR, METÁSTASE NEOPLÁSICA, EXPRESSÃO GÊNICA, NEOPLASIAS GÁSTRICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. BMC Gastroenterology, v. 19, n. 9, p. 10 , 2014Tradução . . Disponível em: http://www.biomedcentral.com/1471-230X/14/9. Acesso em: 01 nov. 2025.
APA
Leal, M. F., Mazzotti, T. K. F., Calcagno, D. Q., Cirilo, P. D. R., Martinez, M. C., Demachki, S., et al. (2014). Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. BMC Gastroenterology, 19( 9), 10 . doi:10.1186/1471-230X-14-9
NLM
Leal MF, Mazzotti TKF, Calcagno DQ, Cirilo PDR, Martinez MC, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications [Internet]. BMC Gastroenterology. 2014 ; 19( 9): 10 .[citado 2025 nov. 01 ] Available from: http://www.biomedcentral.com/1471-230X/14/9
Vancouver
Leal MF, Mazzotti TKF, Calcagno DQ, Cirilo PDR, Martinez MC, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications [Internet]. BMC Gastroenterology. 2014 ; 19( 9): 10 .[citado 2025 nov. 01 ] Available from: http://www.biomedcentral.com/1471-230X/14/9
Artigo de periodico
MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer (2013)
Calcagno, Danielle Queiroz; Freitas, Vanessa Morais ; Leal, Mariana Ferreira; Souza, Carolina Rosal Teixeira; Demachki, Samia; Montenegro, Raquel; Assumpção, Paulo Pimentel; Khayat, André Salim; Smith, Marília de Arruda Cardoso; Santos, Andrea Kely Campos Ribeiro dos; Burbano, Rommel Rodriguez
Source: BMC Gastroenterology. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALCAGNO, Danielle Queiroz et al. MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer. BMC Gastroenterology, v. 13, p. 1-10, 2013Tradução . . Disponível em: https://doi.org/10.1186/1471-230X-13-141. Acesso em: 01 nov. 2025.
APA
Calcagno, D. Q., Freitas, V. M., Leal, M. F., Souza, C. R. T., Demachki, S., Montenegro, R., et al. (2013). MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer. BMC Gastroenterology, 13, 1-10. doi:10.1186/1471-230X-13-141
NLM
Calcagno DQ, Freitas VM, Leal MF, Souza CRT, Demachki S, Montenegro R, Assumpção PP, Khayat AS, Smith M de AC, Santos AKCR dos, Burbano RR. MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer [Internet]. BMC Gastroenterology. 2013 ; 13 1-10.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/1471-230X-13-141
Vancouver
Calcagno DQ, Freitas VM, Leal MF, Souza CRT, Demachki S, Montenegro R, Assumpção PP, Khayat AS, Smith M de AC, Santos AKCR dos, Burbano RR. MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer [Internet]. BMC Gastroenterology. 2013 ; 13 1-10.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/1471-230X-13-141
Artigo de periodico
Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study (2013)
Navarro-Rodriguez, Tomás; Silva, Fernando Marcuz; Barbuti, Ricardo Corrêa; Mattar, Rejane; Moraes Filho, Joaquim Prado Pinto de; Oliveira, Maricê Nogueira de; Bogsan, Cristina Stewart Bittencourt ; Chinzon, Décio; Eisig, Jaime Natan
Source: BMC Gastroenterology. Unidades: FM, FCF
Subjects: PROBIÓTICOS, ÚLCERA PÉPTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAVARRO-RODRIGUEZ, Tomás et al. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterology, v. 13, p. 1-8 art. 56, 2013Tradução . . Disponível em: https://doi.org/10.1186/1471-230X-13-56. Acesso em: 01 nov. 2025.
APA
Navarro-Rodriguez, T., Silva, F. M., Barbuti, R. C., Mattar, R., Moraes Filho, J. P. P. de, Oliveira, M. N. de, et al. (2013). Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterology, 13, 1-8 art. 56. doi:10.1186/1471-230X-13-56
NLM
Navarro-Rodriguez T, Silva FM, Barbuti RC, Mattar R, Moraes Filho JPP de, Oliveira MN de, Bogsan CSB, Chinzon D, Eisig JN. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study [Internet]. BMC Gastroenterology. 2013 ; 13 1-8 art. 56.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/1471-230X-13-56
Vancouver
Navarro-Rodriguez T, Silva FM, Barbuti RC, Mattar R, Moraes Filho JPP de, Oliveira MN de, Bogsan CSB, Chinzon D, Eisig JN. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study [Internet]. BMC Gastroenterology. 2013 ; 13 1-8 art. 56.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/1471-230X-13-56
Artigo de periodico
Lactobacillus acidophilus CRL 1014 improved "gut health" in the SHIME® reactor (2013)
Sivieri, Kátia; Morales, Martha Lissete Villarreal; Adorno, Maria Angela Tallarico; Sakamoto, Isabel Kimiko; Saad, Susana Marta Isay ; Rossi, Elizeu Antônio
Source: BMC Gastroenterology. Unidades: EESC, FCF
Subjects: LACTOBACILLUS, BACTÉRIAS LÁTICAS, PROBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIVIERI, Kátia et al. Lactobacillus acidophilus CRL 1014 improved "gut health" in the SHIME® reactor. BMC Gastroenterology, v. 13, p. 1-9 art. 100, 2013Tradução . . Disponível em: https://doi.org/10.1186/1471-230X-13-100. Acesso em: 01 nov. 2025.
APA
Sivieri, K., Morales, M. L. V., Adorno, M. A. T., Sakamoto, I. K., Saad, S. M. I., & Rossi, E. A. (2013). Lactobacillus acidophilus CRL 1014 improved "gut health" in the SHIME® reactor. BMC Gastroenterology, 13, 1-9 art. 100. doi:10.1186/1471-230X-13-100
NLM
Sivieri K, Morales MLV, Adorno MAT, Sakamoto IK, Saad SMI, Rossi EA. Lactobacillus acidophilus CRL 1014 improved "gut health" in the SHIME® reactor [Internet]. BMC Gastroenterology. 2013 ; 13 1-9 art. 100.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/1471-230X-13-100
Vancouver
Sivieri K, Morales MLV, Adorno MAT, Sakamoto IK, Saad SMI, Rossi EA. Lactobacillus acidophilus CRL 1014 improved "gut health" in the SHIME® reactor [Internet]. BMC Gastroenterology. 2013 ; 13 1-9 art. 100.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/1471-230X-13-100
Artigo de periodico
Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn’s disease (2012)
Nóbrega, Ana Carolina Mello; Ferreira, Bruno Roberto Silva; Oliveira, Graciela Josué; Sales, Kamila Maria Oliveira; Santos, Armenio Aguiar dos; Souza, Miguel Ângelo Nobre e; Braga, Lúcia Libanês Bessa Campelo; Troncon, Luiz Ernesto de Almeida; Souza, Marcellus Henrique Loiola Ponte de
Source: BMC Gastroenterology. Unidade: FMRP
Subjects: DOENÇA DE CROHN, ESVAZIAMENTO GÁSTRICO, ESTUDOS DE CASOS E CONTROLES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NÓBREGA, Ana Carolina Mello et al. Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn’s disease. BMC Gastroenterology, v. 12, 2012Tradução . . Disponível em: https://doi.org/10.1186/1471-230X-12-175. Acesso em: 01 nov. 2025.
APA
Nóbrega, A. C. M., Ferreira, B. R. S., Oliveira, G. J., Sales, K. M. O., Santos, A. A. dos, Souza, M. Â. N. e, et al. (2012). Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn’s disease. BMC Gastroenterology, 12. doi:10.1186/1471-230X-12-175
NLM
Nóbrega ACM, Ferreira BRS, Oliveira GJ, Sales KMO, Santos AA dos, Souza MÂN e, Braga LLBC, Troncon LE de A, Souza MHLP de. Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn’s disease [Internet]. BMC Gastroenterology. 2012 ; 12[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/1471-230X-12-175
Vancouver
Nóbrega ACM, Ferreira BRS, Oliveira GJ, Sales KMO, Santos AA dos, Souza MÂN e, Braga LLBC, Troncon LE de A, Souza MHLP de. Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn’s disease [Internet]. BMC Gastroenterology. 2012 ; 12[citado 2025 nov. 01 ] Available from: https://doi.org/10.1186/1471-230X-12-175

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Indexado em

Non normalized affiliation